Treatment inertia in secondary prevention of cardiovascular disease. FRENA registry

Medicina clínica
Leonor Roaen representación del Grupo FRENA

Abstract

Although nowadays there are many cardiovascular disease (CVD) treatment protocols and evidence based guidelines, not many patients achieve the recommended levels for cardiovascular (CV) risk factor (RF) and management of disorders could be improved. Treatment inertia (TI) is the failure of health care providers to initiate or intensify therapy when indicated. The purpose of this study was to quantify TI in secondary CV prevention and identify factors influencing TI. Observational, transversal study with 1660 patients included in FRENA (The FRENA registry recruited Spanish patients in CVD secondary prevention treated by different specialists), aged 66,3 years, 74% males, 38,5% females, 38,5% coronary heart disease (CHD), 30,8% cerebrovascular disease and 32% peripheral artery disease (PAD). Final variable: TI; three types of inertia where described: treatment failure inertia, RF control inertia and the third one was at least one of the previous. Uni and multivariate analysis were done for each type of inertia. Inertia was detected in 81,5% of the patients. RF control inertia was 85,1% and treatment failure inertia 53%. Diabetic patients are likely to be treated with TI whereas patients with renal insufficiency (RI) or arterial h...Continue Reading

References

Dec 31, 1998·The New England Journal of Medicine·D R BerlowitzM A Moskowitz
Nov 6, 2001·Annals of Internal Medicine·L S PhillipsC S Barnes
May 1, 2004·Hypertension·José R BanegasUNKNOWN CLUE Study Group Investigators
Dec 14, 2005·Atherosclerosis·José R BanegasUNKNOWN HISPALIPID Study Group Investigators
Jan 13, 2006·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators
Apr 9, 2008·European Journal of Internal Medicine·Manuel MonrealUNKNOWN FRENA Investigators
Sep 6, 2008·The Journal of Clinical Hypertension·Gbenga Ogedegbe

❮ Previous
Next ❯

Citations

Apr 23, 2013·Medicina clínica·Anna Baeza RománUNKNOWN Grupo ARIAM-SEMICYUC
Mar 23, 2013·Semergen·F J Alonso MorenoD González-Segura Alsina
Nov 1, 2011·Medicina clínica·Flora López-SimarroSònia Miravet-Jiménez
Mar 25, 2011·Medicina clínica·Jesús MillánXavier Pintó
Nov 22, 2011·Atencion primaria·José María Lobos Bejarano, Carlos Brotons Cuixart
Mar 29, 2014·International Journal of Clinical Practice·A Díaz RodríguezP Valdivielso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Annals of Internal Medicine
L S PhillipsC S Barnes
The New England Journal of Medicine
Philip BarterTreating to New Targets Investigators
© 2022 Meta ULC. All rights reserved